HealthFDA panel votes to place popular peptide BPC-157 on compounding list

Advisers to the U.S. Food and Drug Administration voted on Thursday to add the widely used peptide BPC-157 to a designated list. Inclusion would allow pharmacies to compound the peptide more broadly. The vote concerns how extensively pharmacies may prepare BPC-157 under the agency’s compounding framework. It does not itself describe broader regulatory action beyond the panel’s recommendation.

BPC-157FDApharmacy compounding

RReuters★★★☆☆2026-07-23 21:10Original